B3P-30943-61335
2 vaccinations
1 coded response
26 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 231 / VA
- Registered
- 2022-07-01
- Relationship
- Child or adolescent in my care
- Guardian
- YR7-98486-39288
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-01
Registered in v-safe
-
2022-07-01
Dose 1 — Moderna
- 2022-07-01
- 2022-07-02
- 2022-07-03
- 2022-07-04
- 2022-07-05
- 2022-07-06
- 2022-07-07
- 2022-07-08
- 2022-07-15
- 2022-07-22
- 2022-07-29
-
2022-08-05
Survey response — day 35, dose 1, under 3MedDRA: Pyrexia — Feeling: Good · Be unable to work or attend schoolFree text: Fever for 3 days. No other symptoms.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-11
Dose 2 — Moderna
- 2022-08-12
- 2022-08-13
- 2022-08-14
- 2022-08-15
- 2022-08-16
- 2022-08-17
- 2022-08-18
- 2022-08-25
- 2022-09-01
- 2022-09-08
- 2022-09-17
- 2022-09-22
- 2022-11-10
- 2023-02-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-01 | Moderna | No |
| 2 | 2022-08-11 | Moderna | No |
Free text
Release 12 (Under 3) — day 35, dose 1, under 3
Symptoms: Fever for 3 days. No other symptoms.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release